The SUCLG2 gene helps make a protein in mitochondria, the parts of cells that turn food into usable energy. If this gene does not work properly, cells may struggle to make energy efficiently, which can affect organs with high energy needs. This gene plays an important role in the body’s main energy cycle and in processing a substance called succinyl-CoA. Rare severe variants in the SUCLG2 gene have been linked to mitochondrial disease.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do the work. Other genes mainly help control when, where, and how strongly certain processes take place. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
SUCLG2Gene function
What if the gene works
Inside mitochondria, the SUCLG2 gene helps cells turn food into usable energy. Its protein supports a step in the citric acid cycle, which helps your body make and manage energy.
Risk
What if the gene does not work
Milder to more severe variants in the SUCLG2 gene can reduce how well cells make the GTP form of succinyl-CoA ligase, a mitochondrial energy cycle enzyme. This may weaken one step in cellular energy processing.
Treatment
What does that mean for your treatment
No SUCLG2-specific treatment or drug selection approach is currently established in clinical guidelines for pathogenic or loss-of-function variants in the SUCLG2 gene.
Gene function
What if the gene works
Your cells need a steady way to turn food into usable energy. In your body, the SUCLG2 gene supports processes that help mitochondria release energy from nutrients. It is part of how your body makes energy in mitochondria during normal day to day cell activity.
Inside mitochondria, the SUCLG2 gene helps carry out one step in the citric acid cycle, also called the Krebs cycle. Its protein works with a partner protein to move the pathway from one fuel molecule to the next.
This step captures some released energy as GTP, a small energy carrying molecule. Cells can use GTP for routine tasks and can also shift it into ATP, the cell's main energy currency.
By helping this pathway keep moving, the SUCLG2 gene supports steady mitochondrial activity. This helps cells keep drawing usable energy from food for everyday function.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the SUCLG2 gene can alter how the protein folds, how stable it is, or how well it joins its partner inside mitochondria, which can reduce enzyme activity in the cell’s energy pathway. In practical terms, how SUCLG2 gene variants affect protein function ranges from milder changes that leave some activity to more severe variants that sharply lower or stop it. Some variants may also disturb where the protein is sent within the cell.
How variants are linked to conditions
SUCLG2 does not yet have a broadly confirmed link to a specific health condition, though this may change as research develops. Current evidence on how SUCLG2 gene variants are linked to conditions is still emerging rather than firmly established. Anyone with a confirmed SUCLG2-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Variation in genes is a usual feature of human biology and is widely seen across the general population. Most genetic variants do not directly affect health and simply contribute to normal human diversity. For many genes, a variant connected with a condition points to a possible association, not a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SUCLG2 gene. Anyone worried about personal or family risk can talk with a doctor or genetic counselor for advice based on their own health history.
Inheritance of SUCLG2 variants
There is not yet a broadly confirmed disease specific inheritance pattern for the SUCLG2 gene, so how SUCLG2 gene variants are inherited in relation to a defined condition is still being worked out. As research develops, this picture may become clearer for particular variants and health effects. The SUCLG2 gene is located on chromosome 3, which is an autosome, so a person inherits one copy from each parent.
What does my SUCLG2 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific recognized condition for SUCLG2. If you have a SUCLG2 result and want to understand what it could mean for your relatives, a doctor or genetic counselor can explain it in the context of your exact finding and family history.
Genetic information
Genetic testing
How you find out about variants
A blood sample, saliva sample, or cheek swab can be used for SUCLG2 genetic testing to look for variants in the SUCLG2 gene. Labs read the DNA sequence and compare it with the usual version to identify changes. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
There is not yet a broadly established reason to test the SUCLG2 gene on its own in routine care. Decisions about genetic testing are usually based on your health history, symptoms, and family history, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies depending on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered along with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person but less well for another, or why some people are more sensitive to side effects. Small differences in how the body breaks down, moves, or responds to a drug are common and can influence both benefit and tolerability. Medication response is shaped by genetics along with other factors such as age, kidney and liver function, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SUCLG2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines. If you have concerns about side effects, a treatment not working as expected, or other health changes, talk with your doctor.
History
SUCLG2 entered the genetics literature as researchers mapped the genes involved in the cell’s energy pathways and identified a second partner in the succinyl CoA synthetase family. Initially understood only through visible traits, later recognized as tied to a specific gene, this area of research became clearer as DNA sequencing improved in the late 20th and early 21st centuries. From these first observations, research expanded steadily, especially through studies of mitochondrial conditions that helped place SUCLG2 within a broader medical and biochemical context. Over time, scientists’ understanding of the SUCLG2 gene has become more precise, even though it has remained better known in specialist research than in public discussions.